Norihito Watanabe

Norihito Watanabe

Auto-generated profile, based on publicly available information

Norihito Watanabe

Deparment of Gastroenterology, Tokai University Hachioji Hospital

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2010 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
NWNorihito Watanabe
Norihito Watanabe
ATAtsushi Toyonaga
Atsushi Toyonaga
SKSeiichiro Kojima
Seiichiro Kojima
STShinji Takashimizu
Shinji Takashimizu
KOKazuhiko Oho
Kazuhiko Oho
TTTakashi Tajiri
Takashi Tajiri

20 July 2011
Verified
Journal Article
Closed access
STShinji Takashimizu
Shinji Takashimizu
SKSeiichiro Kojima
Seiichiro Kojima
YNYasuhiro Nishizaki
Yasuhiro Nishizaki
Tatehiro KagawaTatehiro Kagawa
Tatehiro Kagawa
KSKoichi Shiraishi
Koichi Shiraishi
NWNorihito Watanabe
Norihito Watanabe

20 March 2016
Verified
Journal Article
Closed access
JIJin Imai
Jin Imai
HIHitoshi Ichikawa
Hitoshi Ichikawa
HMHajime Mizukami
Hajime Mizukami
TSTakayoshi Suzuki
Takayoshi Suzuki
NWNorihito Watanabe
Norihito Watanabe
TMTetsuya Mine
Tetsuya Mine

1 August 2002
Verified
Journal Article
Closed access
NNNaruhiko Nagata
Naruhiko Nagata
MHMineyoshi Hiyoshi
Mineyoshi Hiyoshi
HSHirokazu Shiozawa
Hirokazu Shiozawa
KSKoichi Shiraishi
Koichi Shiraishi
NWNorihito Watanabe
Norihito Watanabe
SMShohei Matsuzaki
Shohei Matsuzaki
We have speculated that the degree of liver dysfunction in alcoholic liver disease with ALDH2*1/2*2 may be less pronounced than that with ALDH2*1/2*1. In the present study, outpatients with alcoholic liver injury were examined for ALDH2 genotype and biochemical data. The number of patients was 29 cases of nonspecific changes, 16 cases of fatty liver, 5 cases of liver fibrosis, and 44 cases of liver cirrhosis. Biochemical data were evaluated with ALDH2 heterozygotes data obtained by PCR-SSCP. The ALDH2*1/2*1 and ALDH2*1/2*1 genotypes accounted for 90% and 10%, respectively. As for ALDH2*1/2*2, there were three patients with nonspecific changes, three with fatty liver, one with liver fibrosis, and two with liver cirrhosis. In alcoholic liver disease patients, when the ALDH2*1/2*2 genotype was compared with the ALDH2*1/2*1 genotype with biochemical data, the gamma-GTP value in patients with ALDH2*1/2*2 was significantly higher than with ALDH2*1/2*1 ( < 0.005). When the frequency of ALDH2 genotype was determined in patients with alcoholic liver injury, ALDH2 heterozygotes accounted for 15% for the non-cirrhosis group, and 5% for the cirrhotic group. When a relationship between the amount of ethanol intake and biochemical data were determined in patients with alcoholic liver injury who have ALDH2 heterozygotes, the glutamic oxaloacetic transaminase (GOT) and gamma-GTP values were significantly higher at an ethanol intake amount of ethanol more than 100 g per day than intake less than 100 g per day ( < 0.05). The alcoholic patients with ALDH2*1/2*2 drink a slight amount of ethanol, the liver injury is found to be stronger than those with ALDH2*1/2*1 when they drink more than 100 g ethanol per day.

6 September 2007 in Hepatology Research
Verified
Journal Article
Closed access
PDF file
Tatehiro KagawaTatehiro Kagawa
Tatehiro Kagawa
HSHirokazu Shiozawa
Hirokazu Shiozawa
SKSei-Ichiro Kojima
Sei-Ichiro Kojima
STShinji Takashimizu
Shinji Takashimizu
NNNaruhiko Nagata
Naruhiko Nagata
TMTetsuya Mine
Tetsuya Mine